HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) can be divided into transcriptomic subtypes with two broad lineages referred to as classical (pancreatic) and squamous. We find that these two subtypes are driven by distinct metabolic phenotypes. Loss of genes that drive endodermal lineage specification, HNF4A and GATA6, switch metabolic profiles from classical (pancreatic) to predominantly squamous, with glycogen synthase kinase 3 beta (GSK3β) a key regulator of glycolysis. Pharmacological inhibition of GSK3β results in selective sensitivity in the squamous subtype; however, a subset of these squamous patient-derived cell lines (PDCLs) acquires rapid drug tolerance. Using chromatin accessibility maps, we demonstrate that the squamous subtype can be further classified using chromatin accessibility to predict responsiveness and tolerance to GSK3β inhibitors. Our findings demonstrate that distinct patterns of chromatin accessibility can be used to identify patient subgroups that are indistinguishable by gene expression profiles, highlighting the utility of chromatin-based biomarkers for patient selection in the treatment of PDAC.

Citing Articles

Uncovering Potential Biomarkers and Constructing a Prediction Model Associated with Iron Metabolism in Parkinson's Disease.

Cheng Y, Zhai H, Liu Y, Yang Y, Fang B, Song M Neuropsychiatr Dis Treat. 2025; 21:437-449.

PMID: 40041883 PMC: 11878125. DOI: 10.2147/NDT.S511671.

Molecular mechanisms altering cell identity in cancer.

Zippo A, Beyes S Oncogene. 2025; .

PMID: 40011573 DOI: 10.1038/s41388-025-03314-2.

Sialic acid metabolism-based classification reveals novel metabolic subtypes with distinct characteristics of tumor microenvironment and clinical outcomes in gastric cancer.

Jiang J, Chen Y, Zheng Y, Ding Y, Wang H, Zhou Q Cancer Cell Int. 2025; 25(1):61.

PMID: 39987095 PMC: 11847363. DOI: 10.1186/s12935-025-03695-0.

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma.

Liu P, Jacques J, Hwang C Epigenomes. 2024; 8(4).

PMID: 39584964 PMC: 11587027. DOI: 10.3390/epigenomes8040041.

Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma.

Tamagawa H, Fujii M, Togasaki K, Seino T, Kawasaki S, Takano A Nat Cell Biol. 2024; 26(10):1759-1772.

PMID: 39232216 DOI: 10.1038/s41556-024-01498-5.

References

Collisson E, Bailey P, Chang D, Biankin A . Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019; 16(4):207-220. DOI: 10.1038/s41575-019-0109-y. View

Vander Heiden M, Cantley L, Thompson C . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324(5930):1029-33. PMC: 2849637. DOI: 10.1126/science.1160809. View

Biankin A, Piantadosi S, Hollingsworth S . Patient-centric trials for therapeutic development in precision oncology. Nature. 2015; 526(7573):361-70. DOI: 10.1038/nature15819. View

Ying H, Kimmelman A, Lyssiotis C, Hua S, Chu G, Fletcher-Sananikone E . Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012; 149(3):656-70. PMC: 3472002. DOI: 10.1016/j.cell.2012.01.058. View

Pike Winer L, Wu M . Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. PLoS One. 2014; 9(10):e109916. PMC: 4215881. DOI: 10.1371/journal.pone.0109916. View

Bryant K, Stalnecker C, Zeitouni D, Klomp J, Peng S, Tikunov A . Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019; 25(4):628-640. PMC: 6484853. DOI: 10.1038/s41591-019-0368-8. View

Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N . A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009; 15(6):489-500. PMC: 2743093. DOI: 10.1016/j.ccr.2009.03.022. View

Haibe-Kains B, Desmedt C, Loi S, Culhane A, Bontempi G, Quackenbush J . A three-gene model to robustly identify breast cancer molecular subtypes. J Natl Cancer Inst. 2012; 104(4):311-25. PMC: 3283537. DOI: 10.1093/jnci/djr545. View

Zhang , Chung , OLDENBURG . A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 2000; 4(2):67-73. DOI: 10.1177/108705719900400206. View

10.

Biancur D, Paulo J, Malachowska B, Del Rey M, Sousa C, Wang X . Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun. 2017; 8:15965. PMC: 5500878. DOI: 10.1038/ncomms15965. View

11.

Yang A, Kimmelman A . Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status. Autophagy. 2014; 10(9):1683-4. PMC: 4206544. DOI: 10.4161/auto.29961. View

12.

Baek G, Tse Y, Hu Z, Cox D, Buboltz N, McCue P . MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep. 2014; 9(6):2233-49. DOI: 10.1016/j.celrep.2014.11.025. View

13.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

14.

Sherman M, Yu R, Tseng T, Sousa C, Liu S, Truitt M . Stromal cues regulate the pancreatic cancer epigenome and metabolome. Proc Natl Acad Sci U S A. 2017; 114(5):1129-1134. PMC: 5293019. DOI: 10.1073/pnas.1620164114. View

15.

Campbell J, Ryan C, Brough R, Bajrami I, Pemberton H, Chong I . Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines. Cell Rep. 2016; 14(10):2490-501. PMC: 4802229. DOI: 10.1016/j.celrep.2016.02.023. View

16.

Andricovich J, Perkail S, Kai Y, Casasanta N, Peng W, Tzatsos A . Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. Cancer Cell. 2018; 33(3):512-526.e8. PMC: 5854186. DOI: 10.1016/j.ccell.2018.02.003. View

17.

Raeder H, McAllister F, Tjora E, Bhatt S, Haldorsen I, Hu J . Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid. Diabetes. 2013; 63(1):259-69. PMC: 3868055. DOI: 10.2337/db13-1012. View

18.

Yan L, Coletta L, Powell K, Shen J, Thames H, Aldaz C . Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors. PLoS One. 2011; 6(1):e16515. PMC: 3031586. DOI: 10.1371/journal.pone.0016515. View

19.

Embi N, Rylatt D, Cohen P . Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem. 1980; 107(2):519-27. View

20.

Ross-Innes C, Stark R, Teschendorff A, Holmes K, Ali H, Dunning M . Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012; 481(7381):389-93. PMC: 3272464. DOI: 10.1038/nature10730. View